BRIEF-Karyopharm says top-line data from SADAL study expected in second half of 2018
* Karyopharm reports updated Phase 2b SADAL data for Selinexor in diffuse large B-cell lymphoma at the 2017 European Hematology Association Annual Meeting
(Corrects headline and first paragraph to state that Nikkei opened flat)
TOKYO, March 14 Japan's benchmark Nikkei average opened flat at 19,634.29 on Tuesday, while the broader Topix shed 0.02 percent to 1,577.15. (Reporting by Tokyo markets team; Editing by Edmund Klamann)
LONDON, June 23 Investors pulled $7.7 billion from U.S. equities, the biggest outflows in five weeks, data from Bank of America Merrill Lynch (BAML) showed on Friday, reversing the previous week's bumper inflows as bears battled with the bulls.